The purpose of this guidance is to provide sponsors and investigators with recommendations on how to design investigations to assess the outcomes of pregnancies in women exposed to drugs and biological products regulated by FDA (i.e., pregnancy safety studies). The goal of postapproval pregnancy s
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2zBlsqC
No comments:
Post a Comment